Intellectual property law
fromIPWatchdog.com | Patents & Intellectual Property Law
5 days agoCAFC Kills Cancer Treatment Patent Claims Due to Lack of Written Description, Enablement
The 2004 patent application was too broad and failed to provide written description and enablement for the Gly/Phe-only tetrapeptide subgenus claimed in the '039 patent.